Trials / Unknown
UnknownNCT04826562
Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Saint Michael's Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, pilot study of switching patients to Dovato who are currently taking Bitarvy who are virological suppressed (HIV-1 \< 50 copies/mL
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dolutegravir/Lamivudine | single tablet antiretroviral |
Timeline
- Start date
- 2021-09-26
- Primary completion
- 2023-10-06
- Completion
- 2023-12-30
- First posted
- 2021-04-01
- Last updated
- 2023-10-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04826562. Inclusion in this directory is not an endorsement.